SHAREGAIN
UK based Fintech company, Sharegain , whose securities lending platform enables investors to generate revenue by loaning out their financial assets, has appointed Alex Ehrlich to its board of directors.
Mr Ehrlich, who recently retired from Morgan Stanley after ten years as their Global Co-Head of Prime Brokerage, is a well-known leader in the global capital markets, with a 40-year distinguished career on Wall Street. Prior to joining Morgan Stanley, Mr Ehrlich led or co-led the global Prime Brokerage businesses of Goldman Sachs and UBS. He also headed the global Listed Derivatives and Fund Administration businesses of Morgan Stanley, and chaired the Diversity Council of their investment bank.
"I am impressed by the strength of Sharegain’s team and how its technology is beginning to transform the $2.5 trillion securities lending market. I am very excited to join the management team at Sharegain and look forward to contributing to its future success," said Mr Ehrlich.
"We are thrilled to have Alex on-board. Alex brings a wealth of experience and a deep understanding of the capital markets, especially securities lending. We are privileged to have an industry leader of his experience join Sharegain, and look forward to benefiting from his unique insights and inspiring leadership,” said Boaz Yaari, Founder and CEO of Sharegain.
About Sharegain
Sharegain is a UK-Israeli Fintech company democratising the global $2.5 Trillion Securities Lending market. Sharegain have developed a unique platform, utilising cutting edge technology, which has been developed by its pioneering development team in Israel. Sharegain’s value proposition brings the 60-year-old Securities Lending business model into the digital paradigm. It provides institutional investors, including; private banks, asset managers and online brokers, with the benefit of a turn key solution that enables them to lend their securities, with full control, transparency and automation, and no upfront cost.
Find out more about Sharegain at: www.sharegain.com
Disclaimer
With securities lending, as with other investment activities, your capital may be at risk. Sharegain Ltd. is registered in England and Wales (no. 09600298) and is authorised and regulated by the Financial Conduct Authority (no. 730395).
View source version on businesswire.com: https://www.businesswire.com/news/home/20200220005036/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NY-HCLTECH26.4.2024 22:07:31 CEST | Press release
HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY
KINAXIS-INC.26.4.2024 18:04:28 CEST | Press release
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions
VERTEX-PHARMA26.4.2024 17:44:28 CEST | Press release
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
SUZANO-S.A.26.4.2024 17:23:27 CEST | Press release
Suzano 2023 annual report on Form 20-F
MA-TAKEDA-PHARMACEUTICAL26.4.2024 14:31:34 CEST | Press release
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom